⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Neurofilament Light Chain and Clinical Progression in Early Multiple System Atrophy (P5-3.001)

Daniel O. Claassen Paula Trujillo Díaz Amy Wynn Bailu Yan Hakmook Kang Margaret Bradbury Cynthia Wong David Stamler

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

To assess one-year progression of biomarkers and clinical symptoms in Multiple System Atrophy (MSA)

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Claassen et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdb8b6db64358767803d https://doi.org/10.1212/wnl.0000000000206539

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Disease Progression in Multiple System Atrophy: The <scp>ASPIRE</scp> Multi‐Modal Biomarker Study2025 · 8 citations
2Neurofilament Light Chain in CSF and Plasma in Multiple System Atrophy – A Prospective, Longitudinal Biomarker Study (S9.003)2024
3Plasma Neurofilament Light Chain as a Biomarker for Motor Progression and Disease Milestones in Multiple System Atrophy: An Updated Prospective Cohort StudyCohort Study · 2026 · 1 citations
4Magnetic resonance imaging markers predict disease progression in early-stage multiple system atrophy: a 2-year prospective cohort studyCohort Study · 2026
5Glial Fibrillary Acidic Protein in Multiple System Atrophy (P10-7.003)Longitudinal Study · 2026